ONE WEEK LEFT — APPLY NOW

In concert with the society’s mission to improve cancer patient outcomes through the development and application of cancer immunotherapy, SITC is proud to offer its first two-year translational fellowship opportunity, made possible through the generosity of Bristol-Myers Squibb.

• Fellowship Period: December 1, 2016 – November 30, 2018
• Amount: $200,000 ($100,000 per year for two years)

This two-year award offers SITC young investigator members opportunities to obtain dedicated funding to catalyze their research and advance the field of cancer immunotherapy. Eligible candidates must have a MD or combined MD/PhD degree and a vested interest in furthering the research and translation of cancer immunotherapy. In addition to the financial support, the award recipient will also be recognized among peers and luminaries in the field at this year's SITC 31^st Annual Meeting.

Click here to get more information, including the complete list of eligibility requirements. Applicants must be SITC members at time of submission to qualify. Not a SITC member? Get membership information and submit a membership application here.

About the Forward Fund
Since its inception, SITC has strongly supported the growth and achievements of young investigators in the field of cancer immunotherapy. Through the establishment of the Forward Fund, SITC has expanded funding opportunities to provide even more grants that will help attract the brightest young minds in cancer and/or immunology research to the cancer immunotherapy domain. Learn more here.

Society for Immunotherapy of Cancer (SITC)
555 East Wells Street, Suite 1100 | Milwaukee, Wisconsin 53202-3823 USA
Phone: +1 414 271 2456 | Email: info@sitcancer.org

Join us on:

If you do not wish to be included in our mailing list, please forward this message to info@sitcancer.org with the word "Remove" in the subject line.

Please add info@sitcancer.org to your safe senders list.